- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Weight Loss Alone May Not Prevent Diabetes Progression in High-Risk Prediabetes, Finds Study

Germany: A study published in the journal Diabetes found that weight loss alone may not be sufficient to prevent progression from prediabetes to type 2 diabetes in certain high-risk individuals.
- At long-term follow-up, 60 participants achieved at least 3% weight loss, with an average reduction of around 8%.
- Despite sustained weight loss, metabolic outcomes differed significantly across clusters.
- Participants in cluster 5 showed worsening glycemic control compared to other groups.
- Cluster 5 individuals experienced greater increases in fasting glucose and 2-hour post-load glucose levels.
- A significant decline in insulin secretion was observed in cluster 5 participants.
- In contrast, cluster 3 participants demonstrated more favorable metabolic responses.
- Cluster 3 individuals showed improved insulin sensitivity along with preservation of insulin secretion, despite baseline impairment.
- Progression to type 2 diabetes was highest in cluster 5, with approximately 41% developing the condition during follow-up.
- No cases of diabetes were reported in lower-risk clusters (1, 2, 4, and 6).
- About 10% of participants in cluster 3 progressed to type 2 diabetes.
- The findings indicate that substantial and sustained weight loss does not confer equal metabolic benefits across all risk groups.
Dr Kartikeya Kohli, Senior Consultant in Internal Medicine and specialist in diabetes and kidney diseases has done his DNB (Medicine), MRCP (UK). He has also obtained ECFMG Certification from USA in 2011. Also he has done his super-specialist training in Nephrology at IP Apollo Hospital. Dr Kohli is currently practicing as Consultant Internal Medicine at Sitaram Bhartia Institute of Science and Research and Apollo Clinic in East of Kailash. In the past, he has worked with several renowned hospitals in Delhi, including Apollo Hospital, Sir Ganga Ram Hospital & Fortis Vasant kunj. His additional academic qualifications include a PG Diploma in Clinical Endocrinology & Diabetes, Advanced Diabetes Care & Comorbidities, and Advanced Cardiology & ECG from the Royal College of Physicians. Dr Kohli has made significant contributions to medical academics and professional education. He has independently organised more than 100 Continuing Medical Education (CME) programmes and authored over 200 medical articles for various medical bulletins and healthcare portals, including Medical Dialogues.

